ArticleJournal of immunology (Baltimore, Md. : 1950)2026
Longitudinal multiomic and spatial transcriptomic profiling of lupus nephritis progression in a murine model.
Article in Journal of immunology (Baltimore, Md. : 1950), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The chemokine network in lupus nephritis: pathogenesis, targeted therapies, and future directions.Frontiers in pharmacology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
Lupus nephritis (LN), a severe manifestation of systemic lupus erythematosus, is characterized by progressive renal inflammation and tissue injury. To define molecular mechanisms underlying LN progression, we analyzed temporal and spatial transcriptomic profiles in kidneys of lupus-prone New Zealand Black/White F1 mice at 10, 20, and 30 weeks of age, representing preclinical, early, and advanced disease stages. Bulk RNA sequencing revealed minimal transcriptional changes between 10 and 20 weeks but marked shifts by 30 weeks, coinciding with overt nephritis. Differential expression and pathway analyses demonstrated significant upregulation of genes involved in immune cell recruitment, B-cell activation, cytokine signaling, fibrosis, and oxidative stress. To assess translational relevance, we mapped a curated human LN gene signature to orthologous mouse genes. Most orthologs showed significant temporal correlation with disease progression, indicating cross-species concordance and reinforcing the clinical relevance of the model. Spatial transcriptomics of 30-week kidneys identified 9 spatial clusters with distinct expression profiles, including regions enriched for B cells and myeloid cells. One cluster showed high expression of immunoglobulin genes and lymphocyte recruitment markers. Spatial molecular signature analysis identified inflammatory programs enriched for cytokine/chemokine and interferon pathways. Immunofluorescence confirmed peritubular TNFRSF1A expression, CCR5+ inflammatory cell accumulation, compartmentalized NRF2-HMOX1 responses, and CXCL13-associated tertiary lymphoid structure formation. These findings define stage-specific molecular programs and spatially organized immune niches in LN, providing mechanistic insight and potential targets for early intervention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.